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testing technologies for cervical cancer, and Thiopurine Methyltransferase (TPMT) genetic
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1 Introduction
Emerging technologies are radically novel and relatively fast growing technologies characterised
by a certain degree of coherence and with the potential to exert a considerable socio-economic
impact (Rotolo et al., 2015). This impact is conceived in term of changing of existing industries
(Day and Schoemaker, 2000), the basis of competition (Hung and Chu, 2006), and human
understanding or capabilities (Alexander et al., 2012) and it is understood to be long term
(typically with a 15-year horizon or so) (Porter et al., 2002). Change to the status quo promised
by emerging technologies, however, is somewhat uncertain and ambiguous since it lies in the
future (Rotolo et al., 2015). The directionality of emerging technologies is the result of a variety
of factors including visions and expectations of the actors involved (e.g. Collingridge, 1980;
Stirling, 2007; van Lente and Rip, 1998). Emergence is of a reflexive nature: actors are at the
same time regulated by and regulating the emergence process.
For these reasons, the governance of emerging technologies has assumed an increasing rel-
evance, becoming a priority and part of the research agenda of many national governments.
Developing policies to stimulate emergence towards societal benefit as well as to reduce the risk
of the unintended effects or undesirable uses of emerging technologies is, however, a difficult
activity. The governance of emerging technologies also assumes an emergent character resulting
from the multitude of interactions of involved actors whereby the explicit attempts to shape
arrangements are only one part of this process (e.g. Kooiman, 1993; Verbong and Geels, 2007).
Governance is the result of both intentional and un-intentional influences, de facto including fac-
tors and actors non directly or purposefully aiming at governing irreversibilities (David, 1985;
Rip and Van Amerom, 2010). The risk that technological alternatives may be crowded out adds
to this complexity (Martin, 1995).
In this context, the governing of emerging technologies requires tools of ’strategic intelli-
gence’, i.e. tools that are able to provide ’intelligence’ inputs to the decision-making process for
the development of policy instruments capable to cope with the rapid, uncertain, and ambiguous
evolvements of technological emergence (Kuhlmann et al., 1999; Stirling, 2007). Conventional
tools of strategic intelligence include science and technology foresight, innovation policy evalua-
tion, and technology assessment. Frameworks on the use for strategic intelligence of scientomet-
rics in the context of emerging technologies are, however, less explored despite the large variety
of scientometric studies developing approaches for the detection and the analysis of emerging
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technologies (e.g. Gla¨nzel and Thijs, 2012; Porter and Detampel, 1995; Small et al., 2014).
The present paper aims to fill this gap by focusing on a recently developed scientometric
mapping approach, namely overlay mapping (see Rafols et al., 2010). This approach has increas-
ingly attracted the attention of scientometric scholars since its capability to convey relatively
complex information about technological emergence through maps the interpretation of which
does not require advanced scientometric skills (e.g. Klavans and Boyack, 2009; Leydesdorff et al.,
2014, 2013; Waltman and van Eck, 2012). This is achieved by projecting an overlay of data rep-
resenting a focal emerging technology over a basemap, which represents the geographical, social,
and cognitive (or combinations of those) spaces of emergence. For example, the dynamics of an
emerging technology can be traced by projecting longitudinally publications and patents asso-
ciated with the technology over basemap depicting the wider activity in science and technology
(at different levels such as journals, patent classes, research domains) or geographical areas.
To examine the extent to which overlay mapping can aid the governance of emerging technolo-
gies by functioning as a tool of strategic intelligence, we analyse three case-studies of emerging
technologies in the medical domain: (i) RNA interference (RNAi), (ii) cervical cancer testing
technologies for Human Papilloma Virus (HPV) and (iii) genetic testing for the Thiopurine
Methyltransferase (TPMT) enzyme. These are used as ’vignettes’ to generate an integra-
tive synthesis of the ’intelligence’ that different overlay mapping approaches can generate on
technological emergence. For example, once suitable source data are available, analysts and
decision-makers can gather (with relatively low effort thanks to the assistance of publicly avail-
able software routines) ’intelligence inputs’ such as: urban areas producing the large amount
of knowledge as well as the knowledge that is more likely to be of higher future impact; geo-
graphical distributions of key organisational actors in collaborative networks; and identification
of the main scientific disciplines and technological domains involved in the emergence including
dynamics. In addition, overlay mapping techniques provide analysts and decision-makers with
flexibility and granularity in the analytical process.
These tools are flexible in the sense that they are not constrained to the institutional bound-
aries of the databases where relevant data are maintained (Griliches, 1994). Perspectives on
the emergence can be built by using same or similar search strings across multiple sources of
data. Different levels of granularity can be obtained providing the possibility of multiple lev-
els of analysis of the emergence process in order to reveal macro-, meso-, and micro-dynamics.
Flexibility and diverse levels of granularity also favour the integration and comparison of results
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from different contexts. Overlay mapping may also suggest to analysts and decision-makers new
directions of investigation as well as feeding into political discourse in a timely manner.
The paper is structured as follows. In the next section, we introduce the overlay mapping
approach and the diverse possibilities of applications it provides for the analysis of emerging
technologies. We then provide some background to the selected three case-studies and introduce
used data sources in Section 3. This section also discusses an important caveat associated with
the analysis of emerging technologies, that is the delineation of the boundary of what is emerging.
Results of overlay mapping applied to the three case-studies are presented in Section 4. The use
of overlay mapping for strategic intelligence is then discussed in Section 5. Section 6 concludes
by highlighting the contribution of the paper.
2 Scientometric overlay mapping
The scientometric community has made great efforts in the development of techniques to trace
science and technology dynamics since the seminal works by Price (1965), Small (1973), Garfield
(1979), and Callon et al. (1983). Well established examples of these methodological approaches
are direct citation and co-citation analyses (e.g. Garfield et al., 1964; Small, 1977), bibliographic
coupling (e.g. Kessler, 1963), and co-words analysis (e.g. Callon et al., 1983). A multitude
of indicators, which mostly rely on publication and patent data, are based on this type of
scientometric tools.
The growing attention to emerging technologies and their potential to change the status
quo has also led scientometric scholars to focus their efforts on methodological approaches for
the detection and analysis of emergence in science and technology (e.g. Gla¨nzel and Thijs,
2012; Porter and Detampel, 1995; Small et al., 2014).1 These efforts and seminal contributions
on science and technology (S&T) mapping for policy use (e.g. Bo¨rner, 2010; Noyons, 2001),
together with the increase in computational power, the improved performance of processing
algorithms, and the higher technical capabilities in exploiting databases in a more comprehensive
manner, have spurred the development of a number of mapping techniques among which overlay
mapping (e.g. Rafols et al., 2010). The basic idea underlying this approach is depicted in
Figure 1. Overlays are used to project publication and patent data about an emerging technology
1 For a review of the scientometric contribution to the detection and analysis of emerging technologies see Rotolo
et al. (2015).
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over basemaps, which depict the wider activity in science and technology, social structures, or
geographical areas (Figure 1a).2 This process is iterated at different time periods to visualise
dynamics (Figure 1b).
Figure 1: Overlay mapping: basic principle, spaces of emergence (a) and longitudinal overlays (b).
Source: Authors’ elaboration.
A basemap can be conceived as a set of n nodes, a n× n adjacency matrix B describing the
linkages between these nodes, two vectors x and y containing 2D spatial coordinates of nodes,
and a vector c including the information about which clusters nodes belong to:
2 It is worth noting that the application of overlay mapping is not limited to emerging technologies. It can be also
applied to visualise the publishing and patenting activity of individual researchers, organizations (e.g. firms,
universities, research institutes), or communities.
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B =

b11 b12 · · · b1n
b21 b22 · · · b2n
...
...
. . .
...
bn1 bn2 · · · bnn

;x =

x1
x2
· · ·
xn

;y =

y1
y2
· · ·
yn

; c =

c1
c2
· · ·
cn

Nodes can represent cities, authors/inventors, organisations, or knowledge areas (at different
levels such as journals, patent classes, disciplines, topics), while the value of the linkage bij
between nodes i and j (for i, j = 1, 2, . . . , n and i 6= j) can refer to social structures (e.g.
co-authorships), indicate similarity between nodes, or assume value zero in the case of simple
geographical basemaps. It is worth noting that the adjacency matrix is symmetric (bij = bji)
and the diagonal is not used for overlay mapping visualisation purposes, thus it can be assumed
bii = 0. The 2D spatial coordinates of nodes are defined on the basis of the layout algorithm
used to visualise the basemap. The information of how nodes are clustered is often used in the
case of cognitive basemaps to identify different knowledge domains (e.g. disciplines).
Previous research has generated a number of basemaps. These include basemaps of Web
of Science (WoS) Categories (Rafols et al., 2010), journals (Leydesdorff et al., 2013), medical
terms (namely, Medical Subject Headings (MeSH) descriptors) (Leydesdorff et al., 2012), and
patent technological classes (e.g. Kay et al., 2014; Leydesdorff et al., 2014). Google Maps have
been instead used as geographical basemaps (Bornmann and Leydesdorff, 2011; Leydesdorff and
Bornmann, 2012; Leydesdorff and Persson, 2010), while basemaps representing ’global’ social
structures have been less explored.
The set of longitudinal overlays can be described as an array of vectors of n elements:
o1 =

o11
o21
...
on1

,o2 =

o12
o22
...
on2

, · · · ,ot =

o1t
o2t
...
ont

, · · · ,oT =

o1T
o2T
...
onT

where oit indicates the value that the node i of the selected basemap assumes at time period t (for
i,= 1, 2, . . . , n and t = 1, 2, . . . , T ). This, for example, can indicate the number of publications at
time period t that fall within the WoS Category i, are published in the journal i, were produced
by authors based in the city i, etc. These overlays are then projected over the basemap in terms
of size of nodes, while the spatial coordinates of nodes x and y and (if any) clustering c are
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kept constant. This process can be carried out by analysts and decision-makers with relatively
low efforts due to the existence of publicly available software routines. Also, the resulting maps
do not require advanced scientometric skills for their interpretations — notwithstanding the
importance of interacting with experts of the considered case of emerging technology.
The evolutionary perspectives generated with overlay mapping can potentially reveal de facto
(intentional and unintentional) government arrangements among factors and actors involved in
the emergence process. These perspectives may facilitate timely analyses on relevant dynamics
of emergence (e.g. main geographical areas involved in the knowledge production processes and
collaborative interactions among those, main actors in inter-organisational networks and their
geographical distribution, domains of science and technologies involved in the emergence and
associated dynamics across disciplines, journals, technological classes, and, in the case of medical
technologies, medical areas), thus complementing the existing set of more conventional tools of
strategic intelligence for the policy-making of emerging technologies. This, in turn, may support
the development of policy instruments for governance that are more capable to cope with the
rapid dynamics of emergence and associated uncertainty and ambiguity.
Flexibility in the use of diverse sources of data and multiple levels of granularity in the anal-
ysis are additional features that make overlay mappings a useful tool for a ’distributed’ strategic
intelligence on emerging technologies. Results from different contexts can reflexively and discur-
sively be integrated and compared with relatively little additional effort — basemaps provide
common ground for comparisons. The choice of overlays and basemaps, however, depends on
the specific questions the analyst or decision-maker aims to address.
We build on the studies mentioned above to deepen the examination of the use of overlay
mapping as a tool of strategic intelligence for the governance of emerging technologies. It is worth
noting that reiterating the full technical details of developed overlay mapping approaches is not
within the scope of the present paper — the reader is referred to the corresponding studies, which
provide webpages and software routines. We instead aim to provide an integrative synthesis of
different overlay mapping techniques and the types of perspectives on emergence these enable
analysts and decision-makers to generate. To do so, we will apply overlay mapping techniques
to three case-studies of emerging technologies.
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3 Methods
3.1 Background on the case-studies
The case-studies of emerging technologies in the medical domain we examine with overlay map-
ping are: (i) RNAi, (ii) HPV testing technologies for cervical cancer, and (iii) diagnostic tech-
nologies for the TPMT enzyme. These case-studies exhibit diversity in terms of their scale,
breadth of applications and position with regard to alternative technological options. Thus,
from a governance perspective, each technology raises different challenges: RNAi is a tech-
nology with radical potential across the domains of therapeutics, diagnostics and as a basic
research tool, but with fluctuating industrial interest due to technical challenges in delivering
on its promised applications; HPV testing is battling the entrenched technology for cervical
cancer screening, i.e. the Pap testing, with powerful interest groups on both sides; TPMT test-
ing technologies are a much smaller technological field, exploited in a series of small clinical
niches, mainly in developed countries, where there are concerns that best practice may not be
spreading. This diversity of case-studies provides us with the opportunity to discuss the use
of overlay mapping to generate ’intelligence’ inputs for the governance of emerging technologies
in different contexts. However, at the same time, the three case-studies enable us to achieve
a certain degree of external validity of the findings of our analyses (Gibbert et al., 2008; Yin,
2003). The comparison is somewhat controlled since these case-studies are from the medical
domain and share primarily North American origin and similar periods of emergence, in the
1980s and 1990s. One would expect very different dynamics in other contexts such as electronic
engineering — and possibly more difficulties in tracing the technologies with publications and
patents here or in contexts where English language publications are less of a focus for knowledge
producers. In the following, we provide background sketches for the case-studies to contextualise
the scientometric overlay maps presented later in the paper.
Firstly, RNAi is a molecular process that can silence the expression of genes. Gene regula-
tion plays a critical role in the progression of cancers, genetic diseases, and infectious agents.
By silencing specific genes one can stop the progression of some diseases. This ’small RNA’
silencing mechanism was discovered in 1998.3 Its discovery reshaped the landscape of research
on gene expression creating important expectations especially for the therapeutic applications
3 Andrew Z. Fire and Craig C. Mello were awarded the 2006 Nobel Prize in ’Physiology or Medicine’ for this
discovery.
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(Leydesdorff and Rafols, 2011; Sung and Hopkins, 2006).
Secondly, HPV testing technologies are positioned within a specific domain of application,
i.e. the detection of HPV virus, which is recognised as causing cervical cancer.4 Cervical cancer
has a significant disease burden. About 528,000 new cervical cancers occur and cause about
266,000 deaths worldwide each year — 85% and 88% of new cases and deaths affect women in
less developed regions 5 This has led to the development of a large screening program. In the
US more than 100 million tests are performed annually.6 While cervical cancer screening has
been conducted for more than 50 years using the (cytology-based) Pap test to detect cancerous
cells or cells potentially evolving into cancerous states, the discovery of the strong association
between HPV infections (especially HPV types 16 and 18) and cervical cancer in the 1980s
opened the space for the development of a competing and more sensitive testing technology
based on molecular biology (Hogarth et al., 2012, 2016).
Thirdly, similarly to HPV testing, TPMT testing technologies are positioned close to the
applied-research domain. Yet, the clinical utility of TPMT’s application has been contested
across medical fields with different clinical guidelines supporting and discouraging the use of the
test. TPMT testing is one of an emerging class of ’pharmacogenetic tests’ which predict adverse
events associated with pharmaceutical use in individuals that cannot metabolize a drug due to
a genetic mutation (Hopkins et al., 2006). TPMT is an enzyme in the human body responsible
for metabolising (i.e. breaking down) thiopurine drugs. Cytotoxic thiopurine drugs such as Aza-
thioprine are used to treat a range of conditions including leukaemia, and autoimmune diseases
(such as Lupus or rheumatoid arthritis). However, when a patient has mutations in the gene en-
coding TPMT, she/he is unable to metabolise the drug and is at increased risk of toxicity from a
build-up of thiopurines. Following the discovery of genetic variations affecting drug metabolism,
several types of TPMT testing technologies began to emerge in the 1990s with applications
across a number of clinical fields of use such as oncology, dermatology, gastroenterology, and
rheumatology.
4 Harald zur Hausen 1987, who discovered the association between the HPV and cervical cancer, was later awarded
the 2008 Nobel Prize in ’Physiology or Medicine’.
5 GLOBOCAN 2012 available at http://globocan.iarc.fr.
6 ”Health, United States, 2012 - With Special Feature on Emerging Care”, U.S. Department of Health and Human
Services. Available at www.cdc.gov/nchs/data/hus/hus12.pdf.
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Table 1: Data sources and search strings.
Case-study Data Database Search string
RNAi Publications ISI WoS TI=siRNA or TI=RNAi or TI=”RNA inter-
ference” or TI=”interference RNA”
MEDLINE/PubMed siRNA[Title] or RNAi[Title] or ”RNA interfer-
ence”[Title] or ”interference RNA” [Title]
Patents USPTO ACLM/(siRNA or RNAi or ”RNA interfer-
ence” or ”interference RNA”)
HPV testing Publications ISI WoS (TI=HPV* or TI=”Human Papilloma
Virus*” or TI=”Human Papillomavirus*”
or TI=”Human Papilloma*virus*”)
and (TI=Cervical or TI=Cervix) and
(TI=diagnos* or TI=test* or TI=assay or
TI=detect* or TI=screen* or TI=predict*)
MEDLINE/PubMed (HPV*[Title] or ”Human Papilloma
Virus*”[Title] or ”Human Papillo-
mavirus*”[Title]) and (Cervical[Title]
or Cervix[Title]) and (diagnos*[Title] or
test*[Title] or assay[Title] or detect*[Title] or
screen*[Title] or predict*[Title])
Patents USPTO ACLM/((HPV or ”Human Papilloma Virus$”
or ”Human Papillomavirus$”) and (Cervical
or Cervix) and (diagnos$ or test$ or assay or
detect$ or screen$ or predict$))
TPMT testing Publications ISI WoS TI=TPMT or TI= ”Thiopurine Methyltrans-
ferase”
MEDLINE/PubMed TPMT[Title] or ”Thiopurine Methyltrans-
ferase”[Title]
Patents USPTO ACLM/(TPMT or ”Thiopurine Methyltrans-
ferase”)
Source: Authors’ elaboration based on interviews with experts and previous research works on the case-studies.
3.2 Data sources
Overlay mapping mainly relies on two sources of data: publications and patents. We queried
Thomson-Reuter’s Web of Science (WoS) and MEDLINE/PubMed of the US National Library
of Medicine (NLM) for publication data, and the United States Patent and Trademark Office
(USPTO) for patent data. Data for each case-study were gathered with a set of keywords
we identified by triangulating interviews with experts and quantitative research works on the
case-studies (see Table 1). The interviews with experts in the fields of the selected case-studies
are also used as lens of interpretations of the results we obtain from the application of overlay
mapping approaches.
The retrieval of data for emerging technologies is challenging. Research topics often overlap
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and the vocabulary used to describe them is in flux (Robinson et al., 2007). Most up-to-date
methods for retrieval rely on combining lexical search and citation analysis (e.g. Huang et al.,
2015; Zitt and Bassecoulard, 2006), yet these approaches would be time-consuming for the non-
expert analyst. We therefore deemed more suitable to use keyword-based searches given the
parsimony and timeliness of the approach. We limited the search of keywords and their com-
binations in scientific articles’ titles since this approach tends to generate less false positives as
compared to the searching in articles’ abstracts. Abstracts often contain technical and method-
ological terms not representing the core of knowledge the given article claims (Leydesdorff,
1989). An extended search may generally retrieve many additional records, yet with the risk of
including many ones not closely related to the given emerging technology one aims to trace —
it increases ’recall’ at the expenses of losing ’precision’.
The identification of patents that are relevant for the building of informative perspectives
on emerging technologies requires a different approach. The incentives to patent are indeed
different from those underlying the publication of scientific articles. The primary purpose of the
patent system is to reward patentees by providing them a temporary monopoly to commercially
exploit the patented inventions. This requires patentees to disclose the technical knowledge of
the inventions. For this reason, valuable information tends to be included in patent claims that
inform about the scope of the technical knowledge of the considered invention (Hunt et al.,
2007) — claims ”define the invention and are what aspects are legally enforceable” (USPTO
Glossary).7 We therefore focused the search of keywords on patent claims. Issues related to the
definition and delineation of the boundaries of emerging technologies (e.g. the identification of
an effective set of keywords, limited data coverage) are further discussed in the next section.
The number of publications and patents that relate to each of the three case-studies, from
1982 to 2011, are reported in Table 2.8 While the first publications related to TPMT and HPV
stem from the early 1980s, data for RNAi appears only since 1998 when this silencing mechanism
was discovered and first published. Publication data from WoS and MEDLINE/PubMed allow
for relatively simple but informative reports on the emergence of these three technologies in
terms of published scientific articles. Growth can be observed for the three case-studies. Yet, it
is clear that the pace of this growth as well as the scale of this emergence is significantly different
from one case to another in two respects. First, the growth in the number of publications for
7 The USPTO Glossary is available at www.uspto.gov/main/glossary.
8 Data on USPTO patent applications are accessible since year 2001. The filing year of patents was considered.
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RNAi is steeper than the other two case-studies. Second, RNAi and HPV testing technology
show an increasing number of publications for the entire observation period. Conversely, the
testing technology for TPMT enzyme seems to have reached its mature phase, in terms of volume
of publications, in the last few years of observation.
Patent data reveal similar distinctive features. The production of patents (both granted
patents and patent applications) related to RNAi, for example, is relatively greater than in the
case of HPV and TPMT testing technologies. This is not surprising given the former’s wider
scope of potential applications, especially therapeutics where patenting is routine. The apparent
decline of the patenting activity related to RNAi in the last two years of observation is likely
to be due to the delay of 18 months between the patent filing data and the publication of the
patent document on the USPTO. Although most patenting in RNAi occurs in small firms, the
decision of some large pharmaceutical companies, including Merck, Roche and Pfizer, to shut
down their R&D units on RNAi may have also resulted in a decreased interest on RNAi and
contributed to this decline (Lundin, 2011).
The patent application activity around HPV testing technology grows from 2002 to 2004
and then stabilises in the subsequent years with a peak of applications in 2009. The low number
of granted patents and patent applications for TPMT testing technology does not allow clear
trends in the production of technical knowledge to be deduced, other than to note this is a field
that appears to have attracted less attention.
3.3 Definition and delineations issues
A key preliminary input for the use of mapping and overlay techniques is the identification
of a corpus — in this case, publications and patents associated with the emerging technology
one aims to map. This task is generally much more iterative than one initially expects. The
lack of a shared terminology due to the different meanings and expected uses associated with
the technology makes the identification of a suitable set of keywords particularly challenging.
Institutional vocabularies (e.g. MeSH descriptors or patent classifications) may also not be par-
ticularly helpful. Relevant categories (e.g. new terms or classes) may have not been yet included.
This becomes even more problematic for contemporary cases of emerging technologies (Rotolo
et al., 2015), notwithstanding the challenges associated with terminology changes and differing
levels of coverage in datasets (see Hopkins and Siepel, 2013).
The ambiguity of what a ’technology’ is adds to the difficulty of the task. A technology
12
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can include both the knowledge underpinning method or processes to fulfil a purpose (e.g.
understanding of gene silencing) as well as the network of practices and components (e.g. the
molecules and techniques that result in gene silencing). The case of RNAi is apt to highlight
these issues.
RNAi is the naturally occurring process in which gene expression is reduced as a result
of the breakdown of messenger RNAs. This process can be triggered by naturally occurring
(endogenous) molecules, called microRNAs (miRNAs), or by externally inserted (exogenous)
molecules, called small interfering RNAs (siRNAs). Soon after the discovery of RNA interference
by Fire et al. (1998), siRNAs were recognised as valuable for gene silencing, both as tools for
research and for therapeutic purposes. This led to a boom in public and private R&D investments
(Haussecker, 2008, 2012). In parallel, but with some significant delay, it was realised that
miRNAs were not a marginal phenomenon, but played a major role in gene regulation, including
abnormal down or up regulation in certain diseases caused or earmarked by anomalous gene
expression, such as many cancers.
In principle, then, to delineate the research boundary of RNAi one should include both
siRNAs and miRNAs. However, it turns out that ’RNA interference’ as a technology (not as
phenomenon) has become mainly known as the human-induced, exogenous interference, which
was developed for therapeutic purposes. We then have two potential definitions of RNAi, one
covering the entire field and one excluding miRNA — the latter, commonly adopted for the
discussion of therapeutic applications.
Figure 2 illustrates that the observed dynamics are different. Whereas miRNA research
is still booming, possibly due to their potential use as biomarkers in diseases such as cancers,
publications focused on siRNA have reached a plateau of about a thousand publications per year.
The latter is possibly related to the challenges encountered in delivering siRNA in therapeutic
applications that resulted in a retreat of pharmaceutical investment (Haussecker, 2012). These
differences in trends support the views that the uses of miRNAs and siRNAs follow distinct
trajectories, which it is best to differentiate. In this study, we focus on RNAi as research tool
and for therapeutic applications, i.e. not including miRNA, which is not booming any more in
terms of publications, but it is now beginning to reach use in some applications.
There is not an optimal solution to address the fuzziness of the boundaries of emerging
technologies. The analyst often has to carry out a process that may take several iterations and
require a significant interpretative input from experts in the considered technology field before
14
producing a suitable set of keywords for the corpus identification.
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Figure 2: Delineating the boundary of RNAi. Scientific articles related to miRNA were retrieved by using
the following search string in WoS: ’TI=microRNA* or TI=miRNA*’.
Source: Authors’ elaboration on the basis of WoS data.
4 Results
The use of overlay mapping approaches as tools of strategic intelligence for policy-making pro-
cesses is discussed below. We specifically build perspectives on the emergence process of the
three selected case-studies across the geographical, social, and cognitive spaces. The mapping
approach enables the analyst to create syntheses of relatively complex information on the dynam-
ics of emerging technologies and to visualise these in maps. The maps generated can be easily
interpreted and analysed with visual inspection (e.g. emergence of new cities involved in the
production of publications and patents, intensification of the collaboration activity, involvement
of new scientific disciplines or technological areas). For this reason, the results described below
are mostly illustrative and complemented with the qualitative understanding of case-studies.
However, it is worth noting that the aforementioned overlay mapping routines also allow
the analyst to perform quantitative analyses. The overlay data are saved into a relational
database, which can be queried to produce statistical information (for example, to perform
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hypothesis testing) on the focal emerging technology. As discussed, overlay data include: number
of new countries/cities involved with the knowledge creation process, proportional increase of
the number of publications in newly involved disciplines, and indexes of diversity of the scientific
and technological areas involved. Due to space limitations, we discuss and report in this paper
only a few illustrative maps from the results obtained — we instead provide webpages to access
the entire set of overlay maps.
4.1 Tracing emergence in the geographical space
The projection of overlays of publication and patent data over geographical (base)maps can vi-
sualise the emergence process across cities, regions, and nations. Building on previous work (e.g.
Bornmann and Leydesdorff, 2011; Bornmann and Waltman, 2011; Hu et al., 2012; Leydesdorff
and Bornmann, 2012), one can, for example, identify sites for a given emerging technology where
highly-cited scientific articles were published more frequently than expected. This is depicted in
terms of the sizes and colours of nodes — Google Maps are used as geographical (base)maps.9
For the three case-studies of this article, we used overlays projecting publication data corre-
sponding to 5-year time windows.10 Using constant time windows across the case-studies it is
possible to capture the differing pace at which the selected technologies have emerged in terms
of (WoS) publications. Figure 3 depicts the results of the geographical overlay mapping during
the period 2002-2011 (the entire set of maps can be accessed at http://dx.doi.org/10.6084/
m9.figshare.1501068).11
In the case of RNAi (Figure 3a), the mapping shows the emergence of urban areas producing
highly-cited articles on the East Coast of the US near Baltimore and New York, and, especially,
in the area of Boston. The RNAi mechanisms were discovered by groups of scientists working
in Massachusetts (Haussecker, 2008). However, while the maps in the subsequently years report
the emergence of many sites all round the world, Massachusetts has persisted as the main area
producing highly-cited scientific articles — this is revealed by the size of the node — and as one
9 The z− test for two independent proportions is used. The null hypothesis is the randomness in the selection of
papers for a city (see Bornmann and Leydesdorff, 2011). A threshold of top 10% most-frequently cited scientific
articles is selected.
10The time window does not affect the results in this case. Similar dynamics are observed by using narrower or
broader time windows (e.g. 3-year, 7-year). It is worth noting that in order to exploit all the available data up
to the year 2011, the first time window for RNAi is 1998-2001, which includes four years of observations instead
of five years. RNAi can indeed be observed starting from year 1998 when this gene silencing mechanism was
discovered (Fire et al., 1998).
11These maps can be also generated by using patent data (see Leydesdorff and Bornmann, 2012).
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Figure 3: Areas of highly-cited publications for the 2002-2011 period for RNAi (a), HPV (b) and TPMT
(c) testing technologies. Nodes are coloured dark green (red) when the difference between the observed
number of top-cited publications and the expected one is positive (negative) and statistically significant
(p < 0.05), light green (orange) otherwise.
Source: Authors’ elaboration on the basis of WoS data.
of the hubs for RNAi biotech firms.
For the case of HPV testing technologies (Figure 3b), these maps identify, over the en-
tire observation period, European urban areas producing highly-cited scientific knowledge more
frequently than expected in London, Paris, and Amsterdam. New areas have also started to
appear both in the north (nearby Copenhagen, Helsinki, and Jena) and south of Europe (nearby
Barcelona, Bologna, and Turin) since the mid-1990s. The US sites contributing to this emerging
technology with highly-cited articles are mainly located on the coasts, specifically in the area of
Washington D.C., Baltimore, New York, and Boston, for the East Coast, and near San Francisco
and San Diego for the West Coast. Georgetown University and the private company Digene in
the area of Washington D.C. have played a key role for the development and the adoption of a
test for the HPV detection in cervical cancer screening (Hogarth et al., 2012). The maps also
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reveal the rise of new sites producing highly-cited scientific knowledge in South America (e.g.
near Sao Paulo, Buenos Aires) during the last ten years of observation.
This geographical mapping for TPMT testing technology (Figure 3c) locates, at the begin-
ning of the observation period, highly-cited articles in the urban areas of Rochester and Memphis
(US) as well as Sheffield (UK). However, as for HPV testing technology, new sites have started to
appear since 1997 close to the East and West coasts (e.g. areas of Washington D.C., Boston, San
Diego, San Francisco), across the UK (e.g. near London, Glasgow, Edinburgh) and Europe (e.g.
Berlin and Madrid). This analysis shows how overlay mappings can provide the policy-making
process with relevant inputs such as the list of geographical areas where main advancements
for a given emerging technology were achieved and areas that are ’unexpectedly’ listed. It may
also inform on areas that persistently contribute over time to the development of the emerging
technology as well as on new emerging ones.
De facto coordination arrangements are also revealed. For example, the maps for HPV and
TPMT testing technologies identify a number of urban areas in which highly-cited publications
concentrate as located in developing countries. A further analysis of the collaboration networks
(see below) revealed co-authorship links between these areas and others leading the advance-
ments of these emerging technologies in the developed countries. These collaborations may have
provided developing countries with the access to critical capabilities and resources to produce
novel and high-quality knowhow, but perhaps indicating some crucial contribution (e.g. a ge-
netic resource or patient population) needed by researchers in developed countries too that was
helpful.
It is important to note some limitations of the above-discussed approaches. Firstly, the
geographical information reported in publication (and patent) data may not reflect the locations
where the research was conducted. Secondly, while the overlays built at city-level provide high
granularity, they can represent sites located in the same urban area as two different nodes. For
example, in the case of HPV testing technology, Silver Spring (a suburb of the US capital) was
considered as a node different from Washington D.C.. These limitations represent directions for
future development of these techniques.
4.2 Tracing emergence in the social space
The structure of the collaborative relationships among the actors surrounding emerging tech-
nologies and their dynamics play a critical role in the emergence process (e.g. Latour, 1993;
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Powell, 1990). These connections are channels through which actors gain access to and mo-
bilise knowledge, resources, and power. Networks of agents affect and are affected by emerging
technologies, i.e. actors create social structures over the emergence that both enable and con-
strain their actions (Giddens, 1984). By using co-authorship data (e.g. Crane, 1972; Gla¨nzel
and Schubert, 2004; Wagner, 2008), the dynamics across this relevant space of emergence can
be roughly traced — however, it should be noted that many collaborations are not formalised
into co-authorship relations (Laudel, 2002).
The application of overlay mapping in the case of the social space is relatively limited because
one would need to generate a ’global’ collaboration network (at the organisation or author levels)
that would function as basemap for the projection of overlays. Generating such a basemap is,
however, particularly challenging. Differently from geographical and cognitive basemaps, the
’global’ collaborative network is likely to be highly unstable over the observation period (e.g.
actors joining/leaving the network) notwithstanding the considerable effort required to disam-
biguate actors’ names. While the development of this basemap represents an important direction
for future research, here we focus on the type of intelligence about emerging technologies that
can be generated by projecting social structures over the geographical space (Leydesdorff and
Rafols, 2011). For example, Figure 4 shows the collaboration networks at city-level for the HPV
testing case-study. In this map, nodes are cities and the linkages between nodes are traced by
using co-authorship data. Investigating the dynamics across these maps may provide informa-
tive perspectives that are derived by combining the geographical and social spaces. Examples of
key empirical questions the overlay mapping approach may help to address in the policy-making
process are: Where does an emerging technology arise? Does the collaboration network cluster
in specific areas? Does the given emerging technology spread across cities, regions, and coun-
tries and, if yes, through which (collaboration) channels — which types of grant were important,
which size of institutions, or types of knowledge brokers?
The collaborative network of HPV testing technologies, for example, discloses three rele-
vant dynamics of the emergence process. First, strong collaborative activity between the US
(especially the areas of Washington and New York) and Europe (initially Germany) can be
observed. This technology indeed started to emerge after a scientist, Harald zur Hausen, at
the German Cancer Research Centre first proved that HPV infections are strongly associated
with the development of the cervical cancer (zur Hausen, 1987). This discovery subsequently
found important application in the US where extensive screening programs for cervical cancer
19
Figure 4: Overlay of the co-authorship network at city-level for HPV testing technologies in the 1992-2011
period. The size of nodes is proportional to the log2 of the number of scientific articles (plus one) that
the given city published.
Source: Authors’ elaboration on the basis of WoS data.
were already in place and a potential market for new tests was attractive for entrepreneurs.
Here, a small US biotech company, Digene, developed and marketed a series of FDA-approved
HPV tests, now recognised as significant milestones in the evolution of screening technologies
for identification of patients at risk of cervical cancer. A second dynamic that the mapping
reveals is the move, in the last ten years of observation, towards an increasing involvement of
developing countries (e.g. Brazil, India) in the research networks. Cervical cancer in these coun-
tries is a significant social burden and HPV testing was potentially a new relevant approach for
cervical cancer screening in these developing countries. A third dynamic is the globalisation of
research on HPV testing technologies can be observed across the entire period as revealed by
the density of the network of relationships across cities. The latter dynamic is also observed
in the case of RNAi that diffuses all round the world, even more rapidly than HPV testing
technology (the maps of the three case-studies for the entire observation period can be accessed
at http://dx.doi.org/10.6084/m9.figshare.1501086).
Building on these cross-cuttings of the geographical and social spaces, one can focus more
attention on the social dynamics by looking at the structure of the web of relationships composing
the network at a lower level of analysis such as the organisation-level. The network can be
explored with algorithms that identify cohesive groups of organisations as well as public and
private players occupying key positions. Social network analysis provides a broad range of
measures that may support a quantitative assessment of the changes occurring over time in
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Table 3: Descriptive statistics of the co-authorship network at organizational-level for HPV testing tech-
nologies.
Time window 1992-1996 1997-2001 2002-2006 2007-2011
Nodes 173 265 471 816
Ties 223 476 980 2075
Density 0.01 0.01 0.01 0.01
Avarage path length 3.4 2.8 4.4 4.4
Isolated (%) 43 (25%) 47 (18%) 55 (12%) 83 (10%)
Components (min. 3 nodes) 11 16 23 40
First largest comp. (%) 62 (36%) 83 (31%) 239 (51%) 504 (62%)
Second largest comp. (%) 8 (5%) 12 (5%) 14 (3%) 9 (1%)
Degree, Mean (Std.Dev.) 2.6 (3.0) 3.6 (4.8) 4.2 (4.7) 5.1 (5.7)
Source: Authors’ elaboration on the basis of WoS data.
the analysed network.12 In this regard, the analysis of the structure of co-authorship network
at the organizational level for the HPV testing technology case-study (Table 3),13 revealed the
emergence of a giant component as well as an increasing average path length of the network.
A detailed examination showed Digene occupying a strong and influential position within this
network by collaborating with major institutions in the field of cervical cancer screening (e.g.
National Cancer Institute, a public sector sponsor, and Kaiser Permanente, a large healthcare
service provider and early test adopter). This eventually allowed Digene to influence the adoption
of the test, for example by working with clinicians involved in the development of medical
guidelines (Hogarth et al., 2012). In other words, while Digene’s product development activity
was regulated by the FDA, for example, Digene was affecting the developments and dynamics
the use of cervical cancer screening by researchers and practitioners.
The above discussed examples that combined the geographical and social spaces of emer-
gences and moved across units of analysis, in this case from the city to the organisation level,
provides indication of the flexibility and diverse granularity of overlay mapping in generating
intelligence on the constellations of actors involved in the emergence process, structure of the
relationships among these actors, key actors and collaborations shaping the emergence as well
as main channels where knowledge and resources may flow.
12 It is worth noting that the interpretation of some of these measures is difficult because they are size dependent
and networks featuring in emerging technologies show relatively fast growth.
13We use The Vantage Point software to harmonise organisations’ names.
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4.3 Tracing emergence in the cognitive space
As new technologies emerge, epistemic developments occur in terms of discoveries, novel theories,
or changes in technical developments such as experimental systems, materials, methods, and
instrumentation (Joerges and Shinn, 2002; Rheinberger, 1997). These dynamics can be traced
across the cognitive space by creating overlays of publications on basemaps of science that can
be defined at different levels of analysis (e.g. Klavans and Boyack, 2009; Waltman and van Eck,
2012).
The publishing activity related to three case-studies can be, for example, projected across the
map of science defined by the 224 WoS Categories (Rafols et al., 2010). In this map, each node
is a WoS Category that can be assumed as proxy of a scientific subdiscipline. The projection
(overlay) makes a node’s size proportional to the number of publications related to the given
technology that were published in the given discipline the node represents. The different colours
of nodes represent different clusters of disciplines. Figure 5 depicts the projections of publications
related to the three case-studies. We report the map representing the structure of science (left)
— the strength of each linkage is proportional to the similarity of citations patterns of two WoS
Categories — and the heatmap version (right), which shows relative density of publications in a
given area of the basemap.14 This combination provides an intuitive visualisation of the diffusion
process of emerging technologies.
As for the previous analyses, we used overlays projecting the publishing activity according to
5-year time windows. While these maps show the rapid diffusion of RNAi technology as repre-
sented by publications in journals read by many disciplines such as molecular biology, oncology,
biomedical research, and chemistry, the overlays of HPV and TPMT testing technologies reveal
different patterns of diffusion. HPV testing technology diffuses from basic research in oncology,
pathology, and virology disciplines towards issues related to the public health. We interpret this
dynamic as a representation of the extensive and ongoing debate on the practices adopted for
the screening of the population. The debate has been focused on the suitability of HPV testing
technology as first an adjunct to, and latterly a substitute for, the widely adopted Pap test
(Hogarth et al., 2012).
TPMP testing technology diffuses from the basic research in pharmacology towards clini-
cal disciplines such as gastroenterology and dermatology. Publication activity seems to equally
14The visualisations of cognitive maps were produced by using VOSviewer 1.5.4 (van Eck and Waltman, 2010).
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spread in gastroenterology and dermatology disciplines during the 1992-1996 period. Yet, in the
subsequent years, the volume of publications shrinks from dermatology area while continuing to
grow in gastroenterology. This raises questions about the degree to which the use of TPMT test-
ing technologies use has been contested in the different communities such as gastroenterologists,
rheumatologists, and dermatologists.
So far we have indicated in several places that the mapping techniques we have presented
often raise questions that then require further investigation that analysts may want to pursue for
informing the policy-making process. For example, we followed the aforementioned dynamic by
conducting an additional analysis of the content of the scientific articles published by these expert
communities. One potential conclusion may be that fewer publications in dermatology suggests
failure to adopt TPMT testing. However, this is not the case. More fine-grained analysis of
journal article titles and abstracts showed that while the community of dermatologists broadly
accepted the validity of TPMT test, this test is still highly contested in the communities of
rheumatologists and, especially, gastroenterologists. This more intense debate is captured by
the cognitive mapping approach. It is also testified by the strongly worded titles of scientific
articles and presence of a large number of author response/reply or comment articles to other
articles that these two communities published.
A similar cognitive perspective can be built by using a map of which nodes represent academic
journals (Leydesdorff et al., 2013). The map is specifically composed by 10,675 journals (nodes)
(Figure 6a) — the different colours of nodes represent different cluster of journals, i.e. groups
of journals of which the cross-citation patterns are similar. Figure 6b, for example, illustrates
the rapid diffusion of RNAi across this map. RNAi has specifically started to appear in journals
in the basic biomedical science and subsequently it has diffused among a variety of discipline-
specific journals. The Rao-Stirling diversity index, measured on the set of journals of the map,
provides further evidence of this rapid diffusion, especially when the index is compared with
the other two emerging technologies on which we focused our analysis (Figure 6c)15 (journal
overlay maps of the case-studies for the entire observation period can be accessed at http:
//dx.doi.org/10.6084/m9.figshare.1501090).
Perspectives on the cognitive dynamics can be also built by using MeSH descriptors — terms
15The Rao-Stirling diversity is defined as ∆ =
∑
ij pipjdij (Rao, 1982; Stirling, 2007), where dij is a disparity
measure between two classes i and j — the categories are in this case journals — and pi is the proportion of
elements assigned to each class i. Disparity is measured in terms of distances on the journal map (Leydesdorff
et al., 2013).
24
Figure 6: Journal basemap (a), overlay mapping of the RNAi case-study (b), and diversity indexes (c)
for the three case-studies.
Source: Authors’ elaboration on the basis of MEDLINE/PubMed.
used to characterise the content of scientific articles in medical research. These terms are assigned
to articles in MEDLINE/PubMed through an intensive indexing process that is performed by
examiners at the National Institute of Health (NIH). The terms are organised in a 16-branch
tree, which can reach up to 12 levels of depth. Drawing from this classification, Leydesdorff
et al. (2012) developed a MeSH map by using three branches: ”Diseases”, ”Chemicals and
Drugs”, and ”Analytical, Diagnostics and Therapeutic Techniques and Equipment”. The first
two levels of the tree were selected to build the basemap. The map is specifically composed
by 822 MeSH terms (nodes) of which linkages reflect the (cosine) similarity according to co-
occurrence of these terms in scientific articles. Each branch is marked on the map with a
different colour: ”Disease” is coloured red, ”Chemicals and Drugs” green, and ”Analytical,
25
Diagnostics and Therapeutic Techniques and Equipment” blue (see Figure 7a). Similarly to
previous approaches, the publishing activity characterising a given emerging technology can be
projected on this map to trace dynamics across three branches of the MeSH tree.
This approach, applied to the three case-studies, revealed different dynamics. RNAi, in line
with previous results, ’globalises’ across the set of the MeSH terms thus affecting many areas
of the represented branches (Figure 7b). By contrast, HPV testing technology diffuses from the
”Diseases” branch, specifically from ”Tumor Virus Infections”, into the ”Analytical, Diagnostics
and Therapeutic Techniques and Equipment” branch and eventually across the ”Chemicals and
Drugs” area. Yet, interestingly, in the last time window (2007-2011 period) scientific articles
on HPV testing technology concentrate in the techniques and equipment area (Figure 7c). This
may reflect the efforts in developing competing HPV testing technologies. Results also show the
specialisation of the TPMT case-study in more limited areas of the map, reflecting its narrow
range of application (namely a handful of clinical niches) (Figure 7d).
Tracing the patenting activity of emerging technologies provides additional perspectives on
the cognitive dynamics of the emergence process given the diverse incentives featuring in the
creation process of scientific publications and patents. Scholars have developed techniques also
to trace the dynamics of the patenting activities (e.g. Kay et al., 2014; Schoen et al., 2012). The
nodes of these maps are technological classes that, as in the case of previous maps, are linked
by cross-citation (cosine) similarity (Leydesdorff et al., 2015, 2014).
Figure 8, for example, depicts the overlays of RNAi patenting activity on the patent map
based on technological areas as defined by the International Patent Classification (IPC). One can
trace the dynamics in this space by moving across different levels of the classification (e.g. 3-digit,
4-digit). The patent map visualisation revealed the patenting activity of RNAi focused in specific
areas of the technological space such as biochemistry, organic chemistry, and medical science.
While one would expect to observe intense patenting in these technological areas given the nature
of RNAi, this also reveals how one may need to increase, from case to case, the granularity of the
mapping (i.e. lower levels of IPC classes) to build informative and interpretative perspectives
on the observed emerging technology.
Mapping technological emergence in the cognitive space may reveal a number of important
dynamics. These include the directions of diffusion of the given emerging technology across the
key knowledge areas involved in emergence, how those areas may integrate or compete, in which
domains actors’ knowledge production processes are positioned, or, for medical innovation which
26
Figure 7: MeSH basemap (a) and overlay mapping of RNAi (b), HPV (c) and TPMT (d) testing tech-
nologies.
Source: Authors’ elaboration on the basis of WoS data.
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diseases, a technology is addressing and the type of techniques and molecules these efforts are
associated with.
5 Discussion
In cases of the emergence of novel technologies, all actors and particularly policy makers have
very incomplete knowledge, not knowing, for example, where the boundaries of the technology
are, in which direction it is moving, and how it could move forward. In the face of uncertainty,
ambiguity, or ignorance (Stirling, 2007), the emergence process should be investigated and anal-
ysed with strategic intelligence tools in order to support a more informed policy-making process.
We have shown how scientometric overlay mapping can support this process by generating intel-
ligence input across the geographical, social, and cognitive spaces (and combinations of these) of
emergence. Overlay mapping can be somewhat conceived as a monitoring system for emerging
technologies that by tracking emergence and synthesising the complex information in relatively
accessible visualisations can potentially favour the development of policy instruments of a higher
scope, speed, accuracy, and reliability (Nightingale, 2003).
The use of these techniques as a strategic intelligence tool is, however, dependent on a set of
choices that the analyst makes. Although some choices may seem purely technical (e.g. level of
aggregation), in practice they have an interpretative component that may also have important
implications for the type of patterns one can observe (e.g. the granularity of results). Firstly, a
key preliminary choice is to identify the boundary of emerging technologies, i.e. the delineation
of the corpus. For analysts, deciding what to include and what to exclude in the analysis is often
a problematic exercise. In the case of RNAi, for example, one type of delineation portrayed this
technology as already having reached a mature phase, whereas a broader definition suggested
RNAi in a phase of rapid growth (Figure 2). Multiple interactions with experts in the field of
the emerging technology under study therefore assume a critical role in this process.
Secondly, the analyst has to identify appropriate data sources. It is clear that using biblio-
graphic data from publications and patents yields different types of information. Yet, those are
only one form of research outputs. Many other possible dimensions such as products, services,
changes in healthcare outcomes, are not easily accessible for this mapping process. This implies
that some emerging technologies will be well represented in certain datasets and not others. This
may also be the case for certain groups of actors — for example, academic organisations may
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publish more and patent less than private organisations, who may not have as high a propensity
to publish papers as they do to apply for patents. Consideration of available datasets places a
considerable onus on the analyst to find appropriate sources and not to over-interpret limited
data from less appropriate sources.
Studying medical innovations in an IP dominated industry, where regulatory and peer com-
munity pressures encourage publication, is a considerable advantage from the point of view of
data access and availability. However, other contexts may not be so well provisioned, with im-
plications for the utility of the approaches discussed here. The extension of overlay mapping
approach to other types of data sources represents an important challenge for future research
especially when one considers the increasing attention towards the use of ’big data’ and altmet-
rics (e.g. Bornmann and Haunschild, 2015; Thelwall et al., 2013). Social media data may yield
interesting information. Yet these so-called ’altmetrics’ techniques may be more sensitive to
fads and hype than in the databases where the generation of outputs requires more effort (e.g.
publications in WoS, MEDLINE/PubMed, and patent applications).
Thirdly, the selection of the elements to be analysed from the records of the databases as
well as the categories into which the elements are assigned may have a significant impact on
the resulting analyses. From a patent record, for example, one can extract information about
inventors, firms, technology classes, or location, which, as discussed, provide insights on the
social, cognitive or geographical spaces of emergence, respectively. In the case of categories
one needs to decide the level of aggregation (the granularity of the description) as well as the
type of classification — i.e. whether a predetermined, top-down typology is used (e.g. the MeSH
descriptor) or an emerging, bottom-up taxonomy.
Ideally, the choices of databases, elements, and categories can be informed by conceptual
and theoretical frameworks. However, from a policy analyst’s standpoint, it may be also critical
to monitor technological emergence even when there is lack of an explicit understanding of
conceptual frameworks used — policy is needed under conditions of incomplete knowledge. Yet,
even in these cases in which there is no explicit adoption of a conceptual framework, the choice of
specific elements and categories in the analysis is privileging certain understanding over others,
and the implicit assumptions that drive the analysis need to be made clear to ensure the maps
are interpreted within an appropriate context. It is all too easy to misread a map. For example,
looking at collaborative networks of individual scientists implicitly places more attention on the
social capital as a key factor in the emergence process. If one looks at the disciplinary position
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of the technology it is likely to be assuming that integration of disparate knowledge is relevant
as, for example, it has been perceived to be the case of nanotechnologies (e.g. Porter and Rafols,
2009) and in RNAi (Leydesdorff and Rafols, 2011), but not necessarily in HPV or TPMT testing
technologies. In the absence of a clear understanding of the technology, one is advised to explore
the phenomenon by using several perspectives, because one does not know in advance which one
may turn out to be useful for understanding the relations of the emergence in place, or because
the areas in which the action is occurring are shifting over time.
Emerging technologies do not conform to established bodies of knowledge. They cut across
pre-existing organisational and institutional units, challenging established managerial and policy
practices. As a result, one key demand from analysts and decision-makers is a description of the
types of interdisciplinarity or convergence evident in emergence (Schmidt, 2007), often related
with specific visions and expectations (Beckert et al., 2007; Roco and Bainbridge, 2002). In
this regard, building multiple perspectives on the process of emergence requires looking across
databases where emerging technologies ’tumble’ with different representations that stress differ-
ent attributes — such as geographical addresses, WoS Categories, patent classes.
The databases are retained and organized in different contexts with relative institutional
rigidities. For example, relating patents to publications in terms of ’non-patent literature ref-
erences’ requires professional skills and cannot be done on a large scale without substantive
investments. Thus, while the mapping and overlay techniques allow one to use the same or sim-
ilar search strings across these databases more research is required to increase the integration of
datasets. This can already be seen in attempts by US funders, such as the National Institutes
of Health (NIH), to link research grants, patents and publications.16
In summary, while overlay maps are a potentially useful tool for informing decision-making,
the adequacy of this tool for mapping emerging technologies is quite sensitive to a variety of
choices (such as boundary of technology, data sources used, elements and level of granularity
of analyses). Because the maps are generated during emergence, there is a high degree of
uncertainty and ambiguity regarding the choices to be made. As a result, these maps are not
expected to be accurate or even very reliable – they are just heuristic pictures of shapes yet in
the making. The purpose of using multiple dimensions to investigate emergence is to help in
spotting robust insights against patterns that are the result of analytical artifacts.
16See, for instance, http://projectreporter.nih.gov/reporter.cfm
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6 Conclusions
In this article, we have examined the use of scientometric overlay mapping as a tool of strategic
intelligence for the governance of emerging technologies. To do so, we have elaborated a synthesis
of different mapping approaches, and applied these on three case-studies of emerging technologies
in the medical domain to illustrate the variety of ’intelligence’ inputs for the policy-making
process that they can generate. Relevant dynamics of emerging technologies can be illustrated
across the geographical, social, and cognitive spaces, i.e. in terms of geographical distribution
of knowledge processes, collaborative interactions among geographical areas and organisational
actors, and scientific and technological domains emerging or involved. Overlay mapping can
also crosscut sources of data and move across units of analysis (organisations, cities, disciplines,
technologies and sub-fields). This flexibility and diverse granularity favour the comparison of
the results from different policy-making contexts.
The three case-studies of emerging technologies we examined (RNAi, HPV, and TPMT test-
ing) enabled us to elaborate an integrative synthesis of different overlay mapping techniques and
the types of perspectives on emergence these can generate. In the case of HPV and TPMT test-
ing technologies, we showed how different facets and dynamics of the emergence process can be
revealed by moving across the geographical and social spaces from the city-level to organisation-
level units of analysis. The maps also enable the user to compare different technologies and
alternatives in terms of strengths and weaknesses at the portfolio level. As in the case of RNAi,
the mapping can reveal cases of emerging technologies initially concentrated at a few places with
major players hosting the sets of relevant capabilities, competences, and network relationships,
and then diffusing across a number of actors according to preferential attachment mechanisms
(Leydesdorff and Rafols, 2011). On this ’journey’ of the emerging technology, changes in the
involved domains of science and technology — especially in the case of RNAi, the diffusion of
laboratory research tools in other specialties and disciplines — can also be revealed with the
cognitive mapping.
Using overlay maps has some potential problems that need to be addressed during the
study, namely: the delineation issues associated with emerging technologies, the need of some
qualitative background on the studied technology for the interpretation and refinement of the
mapping, the limitations of the data that can be used (mainly publications and patents). If these
problems prove manageable, overlay mapping can function as a heuristic tool that can reveal
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key trends and allow stakeholders to bring relevant data to theoretical and policy debates. Maps
throw new light on relationships and raise additional questions for analysts and decision-makers
to address, thus opening up the space of discussion. The resulting perspectives on emergence,
according to the set of choices an analyst takes, may help debate in a timely manner the directions
of further investigation as well as feeding into political discourse about stumbling blocks ahead
and possible openings in the landscapes.
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